牛膝联合塞来昔布治疗膝骨关节炎临床观察

目的 观察牛膝联合塞来昔布治疗膝骨关节炎(0A)患者的临床效果.方法 将60例OA患者随机分为实验组和对照组各30例,实验组给予牛膝及塞来昔布口服,对照组仅给予塞来昔布口服,疗程4周.应用膝关节骨关节炎自评量表(WOMAC)比较治疗后膝关节功能和症状改善情况,应用ELISA法检测膝关节液中前列腺素E2(PGE2)水平.结果 治疗后4周实验组与对照组WOMAC评分分别为(2.17±1.62)、(3.43±1.76)分,关节液中PGE2水平分别为(21.76±4.10)、(26.20±4.11)ng/L,两组比较P均＜0.05;两组治疗用药过程中无1例出现不良反应.结论 牛膝联合塞来昔布治疗OA临床效果确切,且较为安全.     

紧张型头痛药物治疗的临床研究

目的观察盐酸乙哌立松联合劳拉西泮治疗紧张型头痛的临床疗效。方法选取我院神经内科门诊的紧张型头痛患者75例,口服盐酸乙哌立松和劳拉西泮4周,观察头痛和压痛的变化。结果应用盐酸乙哌立松联合劳拉西泮治疗紧张型头痛4周后,患者的压痛明显减轻,评分与治疗前比较差异有统计学意义（P〈0.01）。治疗总有效率为96%,其中痊愈18例,占24%,显效32例,占42.7%,好转22例,占29.3%。结论对于紧张型头痛患者,应用肌松剂盐酸乙哌立松联合抗焦虑药劳拉西泮进行治疗,疗效满意。     

乙哌立松联合肩宁汤治疗脑卒中后肩手综合征Ⅰ期患者临床疗效观察

目的 观察乙哌立松联合肩宁汤(自拟方)治疗脑卒中后肩手综合征(SHS)Ⅰ期患者的疗效.方法 选取2018年1月至2020年7月在我院住院治疗的脑卒中后SHS Ⅰ期患者100例,随机分为对照组和研究组,每组50例.对照组患者给予乙哌立松治疗,研究组患者给予乙哌立松联合肩宁汤治疗,14 d为1疗程,共治疗2个疗程.比较两组...     

头痛宁胶囊治疗紧张性头痛的临床疗效观察

目的探讨头痛宁胶囊治疗紧张性头痛的临床疗效。方法选择我院2012年紧张性头痛患者92例,将其随机分为治疗组和对照组,治疗组给予头痛宁胶囊联合乙哌立松治疗,对照组给予安定片联合乙哌立松治疗,治疗1个月后对比两组疗效。结果治疗组总有效率为92.3%,对照组总有效率为52.6%,两组疗效比较,差异有统计学意义(P<0.05)。结论头痛宁胶囊治疗紧张性头痛效果好,值得在临床推广。     

乙哌立松结合康复疗法治疗中风后肌痉挛

目的观察乙哌立松结合康复疗法治疗中风后肌痉挛的疗效.方法 58例中风病人随机分为治疗组和对照组,每组各29例.治疗组口服乙哌立松结合康复疗法,乙哌立松为每次50 mg,每日3次,最大剂量为每日300 mg;对照组只应用康复疗法.采用Ashworth分级法和改良的Barthel氏指数评定法,对两组病人治疗前后肌张力及生活活动能力进行评定.结果治疗组治疗后6周病人上下肢肌张力、生活活动能力较对照组均有明显改善（P《0.01）.结论乙哌立松结合康复疗法对中风所致肌痉挛有显著的改善作用,并可提高病人日常生活活动能力.     

硫酸氨基葡萄糖与双氯芬酸治疗膝骨关节炎的临床对照研究

骨关节炎 (osteoarthritis,OA)是一种常见的难治性骨关节疾患 ,以关节软骨破坏为主要特点。膝关节作为负重关节是最易受累的关节之一。OA的传统治疗方法是非甾体抗炎药 (NSAIDs)和局部使用麻醉药物以及体疗等 ,近年来改善软骨代谢的药物受到国内外学者的普遍重视。本文报道具有改善软骨代谢作用的治疗OA慢作用药物硫酸氨基葡萄糖治疗膝关节OA患者 5 1例 ,并与双氯芬酸进行对照 ,以观察两组病人的疗效和药物耐受性。1　资料与方法1 1　病例选择 :10 8例临床确诊为膝OA的患者 ,分为两个治疗组 ,硫酸氨基葡萄糖 (GS)组 5 1例 ,双氯芬酸 …     

独活寄生丸联合塞来昔布对老年膝骨关节炎患者炎性因子、内皮功能及膝关节功能的影响

目的探讨独活寄生丸联合塞来昔布对老年膝骨关节炎(KOA)患者炎性因子、内皮功能及膝关节功能的影响。方法选择老年KOA患者98例,按照随机数字表法分为观察组与对照组各49例。对照组给予塞来昔布治疗,观察组在对照组基础上结合独活寄生丸治疗。两组疗程均为6 w。比较两组疗效,治疗前后关节压痛指数和静息痛指数、血清炎症因子、内皮功能及膝关节功能改善情况。结果观察组治疗总有效率高于对照组,治疗后关节压痛指数和静息痛指数评分低于对照组,白细胞介素(IL)-1、IL-6、IL-8水平低于对照组一氧化氮(NO)水平高于对照组,而内皮素(ET)-1水平低于对照组,Lysholm膝关节评分高于对照组(均P<0.05)。结论独活寄生丸联合塞来昔布对老年KOA患者疗效明显,且降低炎性因子IL-1、IL-6、IL-8水平,改善内皮功能及膝关节功能,具有重要研究意义。     

盐酸多奈哌齐联合脑脉通治疗老年痴呆的作用机制研究

目的探讨盐酸多奈哌齐联合脑脉通治疗老年痴呆的作用机制。方法选择无特定病原体(SPF)级健康雄性SD大鼠50只作为研究对象,随机分为空白组、模型组、盐酸多奈哌齐组、脑脉通组与联合用药组,每组10只。除空白组外,其余各组采用皮下注射D-半乳糖和聚集肽Aβ25~35制备老年痴呆大鼠模型。建模成功后,盐酸多奈哌齐组给予盐酸多奈哌齐0.85 mg/(kg·d)灌胃,脑脉通组给予脑脉通复方制剂1.50 g/(kg·d)灌胃,联合用药组同时给予盐酸多奈哌齐和脑脉通灌胃,空白组和模型组给予生理盐水2.50 mL/(kg·d)灌胃,持续灌胃8周。分别于给药前、给药1周、3周、5周和8周时测定血清糖萼损伤标志物(Syndecan-1、硫酸乙酰肝素)水平。于给药8周后处死各组大鼠,观察各组大鼠脑组织形态,检测脑组织匀浆中白细胞介素(IL)-6、IL-1及肿瘤坏死因子-α(TNF-α)含量和脑源性神经营养因子(BDNF)、神经生长因子(NGF)蛋白表达水平。结果与模型组比较,盐酸多奈哌齐组、脑脉通组和联合用药组脑组织海马神经细胞排列恢复一定的规律性,数量增多。与模型组比较,盐酸多奈哌齐组、脑脉通组与联合用药组炎性因子水平均降低(P<0.05或P<0.01)。与模型组比较,盐酸多奈哌齐组和脑脉通组BDNF、NGF表达水平差异均无统计学意义(P>0.05),联合用药组BDNF、NGF表达水平升高(P<0.01)。与模型组比较,盐酸多奈哌齐组和脑脉通组在灌胃5周时,联合用药组在灌胃3周时,血清Syndecan-1和硫酸乙酰肝素水平降低(P<0.05)。结论盐酸多奈哌齐与脑脉通联合用药对老年痴呆大鼠的改善作用可能是通过保护血管内皮糖萼、抑制炎症反应,进而修复海马神经组织和提高神经营养因子水平实现的。     

欧洲骨质疏松和骨关节炎临床及经济学协会(ESCEO)和中国骨关节炎领域专家联合发表声明:ESCEO膝骨关节炎治疗规则应同样适用于中国患者

2014年12月,欧洲骨质疏松和骨关节炎临床及经济学协会(ESCEO)发布了膝骨关节炎(OA)治疗规则。此篇论文提供了中国OA专家将治疗规则应用于中国临床所做的评估和认可,目的是就如何为膝关节OA患者制定治疗流程提出切实可行的建议。在治疗的第1步,建议采用对症的缓慢起效骨关节炎治疗药物(SYSADOA)作为药物维持疗法,关于SYSADOA只有处方药结晶型硫酸氨基葡萄糖(p CGS)和处方药硫酸软骨素提供了高质量的证据。同时可合并扑热息痛等非甾体抗炎药物(NSAIDs),但只能作为紧急镇痛药物。外用非甾体抗炎药(NSAIDs)也可对症治疗。口服NSAIDs在第2步持续症状的高级治疗中维持核心作用。但是,口服NSAIDs在胃肠道和心血管安全性方面存在较大差异性。关节内注射透明质酸可产生持续临床益处,接受一个治疗疗程后,效应可持续长达6个月。作为手术之前的最后一步,缓释型曲马多(一种较弱的阿片类物质)可产生持续镇痛作用,且耐受性较好。     

全膝关节置换联合云南白药治疗膝关节骨性关节炎的疗效及对ESR、血清CRP、MMP-9水平的影响

目的探讨云南白药联合全膝关节置换对膝关节骨关节炎(OA)及对红细胞沉降率(ESR)、血清C反应蛋白(CRP)、基质金属蛋白酶(MMP)-9的影响。方法 OA患者80例,根据随机数字表法分观察组和对照组,每组40例,均实行全膝关节置换术,对照组于术后第1天始,给予云南白药胶囊4 w,4次/d,2粒/次。比较两组术后疼痛程度及治疗前后血清ESR、血清CRP、MMP-9水平。结果与治疗前相比,治疗后两组ESR、CRP、MMP-9水平均下降且观察组低于对照组(均P<0.05),观察组治疗优良率高于对照组(P<0.05)。结论云南白药联合全膝关节置换术能够降低OA患者血清CRP、ESR、MMP-9水平。     

悬吊技术联合Mulligan手法对膝骨关节炎老年人群运动后疼痛的康复效果

目的 探究悬吊技术联合Mulligan手法用于膝骨关节炎老年人运动后膝关节疼痛康复的效果.方法 选取84例单侧膝关节运动后疼痛的膝骨关节炎老年患者,依据随机数字表法分为观察组和对照组,各42例.对照组给予常规物理治疗与悬吊训练治疗,观察组在对照组基础上给予Mulligan技术治疗.比较两组治疗开始前与治疗后视觉模拟评分(VAS)疼痛评分、QOL-BREF评分、LEFS下肢功能评分、膝关节功能评分、关节活动度、四头肌与腘绳肌肌力.结果 两组治疗后VAS评分明显降低(P<0.05),且观察组VAS评分明显低于对照组(P<0.05).两组治疗后QOL-BREF评分/LEFS评分、膝关节功能评分、关节活动度、四头肌与腘绳肌肌力较治疗前明显提高(P<0.05),且治疗后观察组QOL-BREF评分/LEFS评分、膝关节功能评分、关节活动度、四头肌与腘绳肌肌力明显高于对照组(P<0.05).结论 对于膝关节运动后疼痛的膝骨关节炎老年患者,悬吊技术联合Mulligan手法,能有效缓解膝关节疼痛、促进膝关节功能恢复,提高患者生活质量.     

Effect on lung function of methotrexate and non-steroid anti-inflammatory drugs in children with juvenile rheumatoid arthritis

We evaluated lung function in a group of patients affected by juvenile rheumatoid arthritis (JRA), without clinical and/or radiological signs of respiratory involvement. We compared the effects on pulmonary function of methotrexate (MTX) therapy combined with non-steroid anti-inflammatory drugs (NSAIDs) to those of NSAIDs alone and correlated lung function to subtype onset, disease duration and disease activity. Our patients were 27 JRA children, subdivided into two groups according to the therapy (group A=14 patients, treated with a low dose of MTX and NSAIDs; group B=13 patients, treated with NSAIDs alone). Clinical evaluation, haematological data and pulmonary function tests (PFTs) were obtained in each group at baseline (time 0) and at 1 year (time 1). At time 0 and time 1 PFTs were altered in 51.8% of JRA patients. The restrictive pattern (reduced forced vital capacity, FVC) was the most frequent feature, observed in 22.2% of patients. In group A the mean values of FVC, FEV1 (forced expiratory flow in 1 s), FRC (functional residual capacity), TLC (total lung capacity) and DLCO (diffusing lung capacity of carbon monoxide) were significantly lower compared to those of group B, at time 0 and at time 1. No functional parameter was correlated to subtype, duration or activity of the disease. Our study confirms that abnormalities in PFTs may be detected in JRA patients, even in the absence of clinical and/or radiological signs of lung disease; MTX in combination with NSAIDs does not seem to affect lung function at 1 year more than NSAIDs alone. Received: 3 November 1997 / Accepted: 21 December 1997     

Effect of nonsteroidal anti-inflammatory drug plasters for knee osteoarthritis in Japanese: a randomized controlled trial

The objective of this study was to examine the effect of a nonsteroidal anti-inflammatory drug (NSAID) plaster for knee osteoarthritis among Japanese patients. An open-labeled, randomized, controlled, multiclinic trial was performed involving outpatient clinic groups. Two comparative groups—plaster NSAIDs and oral NSAIDs—were randomly allocated. The drugs used were limited to the current top three in both groups in Japan. Treatments were assessed after four weeks and compared with the baseline scores. Outcomes were evaluated by two psychometric measures: Japanese knee osteoarthritis measure, and pain with the visual analogue scale. The total number of patients included in the final evaluation was 165 (87 for the plaster group and 78 for the oral group). Between these two groups there were no significant differences in gender, age, body height and weight, body mass index, and X-ray grading. The subjects in both groups showed improvements in both scores at the end of intervention. The differences in the improvements in scores between the two groups were not significant, though the mean rank score and the 95% CI of the plaster group were slightly better than those of the oral group. In conclusion, the local application of a plaster with NSAIDs leads to the same level of improvement in knee osteoarthritis as oral NSAIDs.     

生长抑素联合铝碳酸镁对非甾体抗炎药致老年急性出血糜烂性胃炎患者的疗效分析

目的 探讨生长抑素联合铝碳酸镁对非甾体抗炎药（NSAIDs）致老年急性出血糜烂性胃炎患者的疗效.方法 将136例NSAIDs致老年急性出血糜烂性胃炎患者随机分为观察组和对照组,对照组给予铝碳酸镁片治疗,观察组在对照组的基础上加用生长抑素,比较两组黑便、大便潜血消失时间、住院时间及治疗有效率.结果 观察组黑便、大便潜血消失时间、住院时间均低于对照组,与对照组比较差异有统计学意义（P＜0.05）.观察组治疗后总有效率高于对照组,与对照组比较差异有统计学意义（P＜0.05）.结论 生长抑素联合铝碳酸镁对NSAIDs致老年急性出血糜烂性胃炎患者的治疗效果较好,可缩短患者住院的时间,改善患者临床症状,有效抑制出血,具有较好的应用价值.     

双醋瑞因、硫酸氨基葡萄糖联合透明质酸钠治疗膝骨关节炎疗效观察

目的研究双醋瑞因、硫酸氨基葡萄糖联合透明质酸钠治疗膝骨关节炎的临床疗效。方法将160例骨关节炎患者随机分为2组,治疗组80例给予双醋瑞因50mg,口服,1次／天,硫酸氨基葡萄糖胶囊500mg,口服,3次／天,共服药12周;透明质酸钠注射剂2．5ml膝关节腔内注射,每周1次,连续5周为1个疗程。对照组80例仅予双醋瑞因和硫酸氨基葡萄糖口服（剂量、疗程同前）观察治疗前、治疗后12周、24周临床疗效指标、炎性指标和影像学表现改善情况。结果12周时2组患者在临床疗效指标、炎性指标方面较治疗前比较均显著改善（P均〈0．05）;治疗组改善程度优于对照组（P〈0．05）。24周时,治疗组的临床疗效指标、炎性指标等均较治疗前改善（P〈0．05）,但改善程度较12周时下降（P〈0．05）,但仍优于对照组（P〈0．05）,此时影像学表现方面有改善（P〈0．05）;对照组的临床疗效指标、炎性指标和影像学表现等与治疗前比较无明显改善（P〉0．05）。治疗过程中,两组患者均未发生严重不良反应。结论双醋瑞因和硫酸氨基葡萄糖联合透明质酸钠治疗膝骨关节炎是可行、安全、优效、便捷、疗效持久的方案,值得临床推广。     

关节腔内注射联合康复训练治疗膝关节骨性关节炎临床观察

目的 观察关节腔内注射透明质酸钠联合康复训练治疗膝关节骨性关节炎(KOA)的临床疗效及对血浆β-内啡肽和P物质含量的影响.方法 将106例膝关节骨性关节炎患者分为治疗组及对照组,治疗组给予关节腔内注射透明质酸钠及康复训练治疗,对照组仅给予康复训练治疗.于治疗前、治疗6周后及随访3个月、6个月时采用Lysholm功能评分对2组患者膝关节功能进行评定,同时对2组患者血浆β-内啡肽及P物质含量进行检测.结果 治疗6周后及随访3个月、6个月时,2组患者膝关节功能评分均较治疗前明显改善(P＜0.01),且均以治疗组的改善幅度较显著,与对照组比较,组间差异均有统计学意义(P＜0.01).2组患者治疗后,其血浆β-内啡肽含量均明显增高,P物质含量均显著降低,并以治疗组的变化幅度较显著,与对照组间差异有统计学意义(P＜0.01).结论 关节腔内注射透明质酸钠联合康复训练治疗膝关节骨性关节炎,能有效改善膝关节功能,且疗效持久,同时能显著提高KOA患者血浆β-内啡肽活性,降低P物质含量,对缓解疼痛、提高膝关节活动功能具有重要意义.

Abstract：

Objective To observe the clinical effect of intra-articular injection of sodium hyaluronate combined with rehabilitation training in treatment of knee osteoarthritis, and their effects on β endorphin and substance P levels in plasma. Methods All 106 cases with knee osteoarthritis were divided into treatment group and control group. Treatment group were treated by intra-articular injection of sodium hyaluronate combined with rehabilitation training, and control group underwent rehabilitation training only. Knee joint function was evaluated using Lysholm scores before and six weeks after treatment, and at 3-month and 6-month follow-up. Meanwhile, the concentrations of β endorphin and substance P in plasma were tested in the two groups. Results Compared with pre- treatment, the Lysholm scores were obviously increased after 6-week treatment, at 3-month and 6-month follow-up in both groups, with more obvious increase in treatment versus control group (P＜0.01). The Lysholm scores were higher in treatment group than in control group (P＜0.01). The concentration of β endorphin in plasma was significantly increased, and the substance P concentration in plasma was decreased after treatment in both groups. There were also significant differences in concentrations of β endorphin and substance P in plasma between treatment group and control group (P＜0.01). Conclusions Intra-articular injection of sodium hyaluronate combined with rehabilitation training is effective in improving knee joint function in elderly patients, in relieving pain and in enhancing joint movement.     

关节镜清理术联合玻璃酸钠注射治疗膝关节骨性关节炎的临床观察

目的探讨关节镜清理术联合玻璃酸钠药物注射治疗膝关节骨性关节炎的临床效果。方法将2017年6月至2019年3月本院收治的98例膝关节骨性关节炎患者按随机数字表法分为试验组与对照组,各49例。试验组接受关节镜清理术联合玻璃酸钠药物注射治疗,对照组接受单独关节镜清理术治疗。观察两组治疗前后关节疼痛程度、关节液炎症细胞因子表达、膝关节功能及并发症发生率。结果相较于治疗前、治疗后24小时、4个月两组关节疼痛VAS评分均降低,且试验组评分低于对照组,差异有统计学意义(P<0.05)。相较于治疗前,治疗后4个月两组关节液内IL-1β、TNF-α表达均降低,且试验组IL-1β、TNF-α表达分别为(309.64±20.48)pg/ml、(425.37±32.24)pg/ml,低于对照组的(328.76±21.63)pg/ml、(463.31±35.09)pg/ml,差异有统计学意义(P<0.05)。相较于治疗前,治疗后4个月两组膝关节功能均改善,且试验组(79.53±1.57)分高于对照组的(70.36±1.68)分,差异有统计学意义(P<0.05)。两组并发症总发生率对比(14.29%vs 10.20%),差异无统计学意义(P>0.05)。结论关节镜清理术联合玻璃酸钠药物注射治疗膝关节骨性关节炎疗效确切,能减轻或消除关节疼痛等症状,降低炎症反应,改善患者膝关节功能,且并发症少,值得推广。     

Comparison of two different viscosupplements in knee osteoarthritis – a pilot study

 A pilot study was designed to investigate the efficacy of two different hyaluronic acid preparations combined to physical therapy in patients with knee osteoarthritis in terms of reduction in pain and disability and muscle strengthening. Thirty-seven patients with symptomatic osteoarthritis of the knees were randomly assigned into three groups. First group received a lower molecular weight hyaluronic acid plus physical therapy, second group received a higher molecular weight hyaluronic acid plus physical therapy, and the third group received physical therapy alone. The isokinetic knee muscle strengths and index of severity for osteoarthritis of the knee scores were evaluated at baseline, at the end of treatment (3 weeks) and at 3 months of follow up. At both short-term (3 weeks) and long-term (3 months) evaluations, index of severity for osteoarthritis of the knee scores were reduced in all three groups, while there was no significant muscle strengthening. Received: 13 May 2002 / Accepted: 21 November 2002     

Evaluation of the renal injury from gold salts and nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis

Summary The urinary excretion of proteins, N-acetil-3-glucosaminidase and leucine aminopeptidase, was measured in 50 patients with rheumatoid arthritis (RA), of whom 20 subjects were on nonsteroidal anti-inflammatory drugs (NSAIDs) and 30 on gold salts. No pathological changes of the above-mentioned urinary parameters have been observed in the group of RA patients, in comparison with control subjects and patients suffering from osteoarthritis treated with NSAIDs.     

雷贝拉唑对NSAIDs相关小肠损伤大鼠紧密连接蛋白Occludin表达的影响及其机制

目的探讨雷贝拉唑对非甾体类抗炎药(NSAIDs)相关性小肠损伤大鼠紧密连接蛋白Occludin表达的影响及可能的机制。方法将36只SD大鼠随机平均分为阴性对照组、双氯酚酸损伤组和雷贝拉唑处理组。采用双氯酚酸7.5 mg/(kg.d)灌胃,连续4 d,制造大鼠NSAIDs相关性小肠损伤模型;而雷贝拉唑处理组在每次造模前0.5 h予以15 mg/(kg.d)雷贝拉唑灌胃处理,连续4 d。处死大鼠进行大体及病理观察小肠损伤情况,采用免疫组织化学和Western blot方法检测小肠组织中Occludin和磷酸化ERK(p-ERK)蛋白表达水平的变化。结果雷贝拉唑处理组大鼠大体和病理损伤均低于损伤组(P<0.05)。Occludin蛋白在损伤组中表达较对照组明显下降(P<0.05),而在雷贝拉唑处理组中的表达较损伤组上升(P<0.05);与阴性对照组相比,p-ERK蛋白在损伤组中表达上升(P<0.05),在雷贝拉唑处理组中的表达较损伤组下降(P<0.05)。结论雷贝拉唑对大鼠NSAIDs相关性损伤有保护作用,其机制可能是通过MAPK中的ERK途径,增加小肠上皮组织中Occludin蛋白表达,从而增强肠黏膜屏障功能。